Clicky

Recursion Pharmaceuticals, Inc.(RXRX)

Description: Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. It has four clinical-stage drug candidates focused on rare, monogenic diseases; and 33 additional programs in various stages of preclinical development. Recursion Pharmaceuticals, Inc. has strategic agreements with Bayer; Ohio State Innovation Foundation; Chromaderm, Inc.; and Takeda Pharmaceutical Company Limited. The company was founded in 2013 and is based in Salt Lake City, Utah.


Keywords: Biotechnology Health Sciences Health Care Drug Discovery Pharmaceutical Sciences Takeda Pharmaceutical Company Monogenic Diseases Rare

Home Page: www.recursion.com

RXRX Technical Analysis

41 South Rio Grande Street
Salt Lake City, UT 84101
United States
Phone: 385 269 0203


Officers

Name Title
Dr. Christopher C. Gibson Ph.D. Co-Founder, CEO & Director
Ms. Tina Marriott Larson COO & Pres
Dr. Blake C. Borgeson Ph.D. Co-Founder & Director
Dr. Michael Secora Ph.D. Chief Financial Officer
Dr. Shafique Virani M.D. Interim Chief Medical Officer & Chief Bus. Officer
Kevin Leggat VP of Fin. & Accounting
Mr. Benjamin Mabey M.S. Chief Technology Officer
Mr. Jared Allenbach Sr. Director of Investor Relations
Ms. Louisa Daniels J.D., M.B.A. Chief Legal Officer & Gen. Counsel
Mr. Ryan Kelly Chief Communications Officer

Exchange: NASDAQ

Country: US

Currency: US Dollar ($)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 4.46
Price-to-Sales TTM: 55.9421
IPO Date: 2021-04-16
Fiscal Year End: December
Full Time Employees: 400
Back to stocks